Abbott Laboratories (ABT) reported second-quarter 2024 adjusted earnings per share (EPS) of $1.14, which beat the Zacks Consensus Estimate by 3.6%. The metric also topped 5.6% from the prior-year quarter’s level. The quarter’s adjustments include 40 cents of certain non-recurring items.GAAP EPS came in at 74 cents, down 5.1% year over year.Second-quarter worldwide sales of $10.38 billion were up 4% year over year on a reported basis. The top line exceeded the Zacks Consensus Estimate by 0.3%.Organically, sa ...